Literature DB >> 16301185

How many people develop fractures with what outcome?

Terence W O'Neill1, Dipak K Roy.   

Abstract

Osteoporosis is an important clinical and public health problem because of its association with fractures. Osteoporotic fractures result in significant morbidity, mortality and health and social care costs. Hip fracture is the major adverse health consequence associated with the disease, although other fractures are also linked with significant adverse outcomes. Because of current demographic trends, the number of men and women with osteoporosis and osteoporotic fractures is set to increase dramatically over the next 50 years unless effective preventive measures are adopted. Over and above this demographic trend there is evidence that the age-specific rates of fractures have increased during the last century. This chapter reviews the epidemiology of osteoporotic fractures, including their occurrence, descriptive epidemiology and impact.

Entities:  

Mesh:

Year:  2005        PMID: 16301185     DOI: 10.1016/j.berh.2005.06.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  14 in total

1.  Short-term and long-term site-specific effects of tennis playing on trabecular and cortical bone at the distal radius.

Authors:  Gaële Ducher; Nicolas Tournaire; Anne Meddahi-Pellé; Claude-Laurent Benhamou; Daniel Courteix
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

2.  Effect of vertebral fractures on function, quality of life and hospitalisation the AGES-Reykjavik study.

Authors:  Kristin Siggeirsdottir; Thor Aspelund; Brynjolfur Y Jonsson; Brynjolfur Mogensen; Lenore J Launer; Tamara B Harris; Gunnar Sigurdsson; Vilmundur Gudnason
Journal:  Age Ageing       Date:  2012-02-23       Impact factor: 10.668

3.  Leisure time physical activity and risk of non-vertebral fracture in men and women aged 55 years and older: the Tromsø Study.

Authors:  Bente Morseth; Luai A Ahmed; Åshild Bjørnerem; Nina Emaus; Bjarne K Jacobsen; Ragnar Joakimsen; Jan Størmer; Tom Wilsgaard; Lone Jørgensen
Journal:  Eur J Epidemiol       Date:  2012-03-04       Impact factor: 8.082

4.  Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies.

Authors:  Marlies R de Jong; Maarten Van der Elst; Klaas A Hartholt
Journal:  Ther Adv Drug Saf       Date:  2013-08

5.  Use of recombinant human parathyroid hormone(1-84) in patients with postmenopausal osteoporosis: a prospective, open-label, single-arm, multicentre, observational cohort study of the effects of treatment on quality of life and pain--the PROPOSE study.

Authors:  Rüdiger Möricke; Klaus Rettig; Thomas D Bethke
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

6.  Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: Incorporating new agents into clinical practice.

Authors:  Alan So; Joseph Chin; Neil Fleshner; Fred Saad
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

7.  Polytrauma in the elderly: specific considerations and current concepts of management.

Authors:  R Dimitriou; G M Calori; P V Giannoudis
Journal:  Eur J Trauma Emerg Surg       Date:  2011-07-29       Impact factor: 3.693

8.  Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

Authors:  Eric S Meadows; Beth D Mitchell; Susan C Bolge; Joseph A Johnston; Nananda F Col
Journal:  BMC Womens Health       Date:  2012-01-06       Impact factor: 2.809

9.  Increased mortality after upper extremity fracture requiring inpatient care.

Authors:  Axel Somersalo; Juha Paloneva; Hannu Kautiainen; Eija Lönnroos; Mikko Heinänen; Ilkka Kiviranta
Journal:  Acta Orthop       Date:  2015       Impact factor: 3.717

10.  Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study.

Authors:  Bente Morseth; Hasse Melbye; Svanhild Waterloo; Marte R Thomassen; Marijke J Risberg; Nina Emaus
Journal:  BMC Geriatr       Date:  2013-10-29       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.